The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pronomz Ventures LLP
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts less than Nifty Smallcap 250 and 5.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Pronomz Ventures LLP, part of the promoter and promoter group of Onesource Specialty Pharma, purchased 33,906 equity shares in the open market on January 30, 2026. This is a disclosure under SEBI Takeover Regulations 29(2). The acquisition raised the combined promoter group holding from 30.17% (3,45,71,199 shares) to 30.19% (3,46,05,105 shares) of the company's total equity share capital of 11,46,21,201 shares. The total value of the acquisition is small given the marginal 0.03% increase in stake, and the mode of acquisition is purely open market purchase. The filing was signed by Designated Partner Jyothinagaravyasha Sriraman Ramaprasad on February 2, 2026.
This is a minor open-market purchase by the promoter group showing continued confidence in the company, but the negligible size (just 0.03% increase) means it is unlikely to have any meaningful impact on the stock price. Shareholders can take it as a routine promoter activity disclosure under SAST rules.